Literature DB >> 16982084

Pharmacotherapy of aphasia: myth or reality?

Xavier de Boissezon1, Patrice Peran, Chloé de Boysson, Jean-François Démonet.   

Abstract

Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents. Here, we reviewed the MEDLINE available reports of drug therapy for aphasia. So far, proofs of efficiency were found indubitable for none of the studied molecules. However, some of them showed limited efficiency (piracetam and amphetamine). Moreover, drug therapies for aphasia were less efficient alone than when they were associated with speech therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982084     DOI: 10.1016/j.bandl.2006.07.004

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  14 in total

1.  The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.

Authors:  Qi Xie; Yan Liu; Chun-Yong Li; Xue-Zhu Song; Jun Wang; Li-Xin Han; Hong-Min Bai
Journal:  Psychopharmacology (Berl)       Date:  2012-05-04       Impact factor: 4.530

Review 2.  Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke.

Authors:  Xabier Beristain; Esteban Golombievski
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

3.  Psycholinguistics of Aphasia Pharmacotherapy: Asking the Right Questions.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Abigail Oveis
Journal:  Aphasiology       Date:  2014-01-01       Impact factor: 2.773

Review 4.  Neuroscience insights improve neurorehabilitation of poststroke aphasia.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller
Journal:  Nat Rev Neurol       Date:  2011-02       Impact factor: 42.937

5.  Paroxetine-induced modulation of cortical activity supporting language representations of action.

Authors:  Patrice Péran; Jean-François Démonet; Dominique Cardebat
Journal:  Psychopharmacology (Berl)       Date:  2007-09-18       Impact factor: 4.530

6.  The future of restorative neurosciences in stroke: driving the translational research pipeline from basic science to rehabilitation of people after stroke.

Authors:  Binith Cheeran; Leonardo Cohen; Bruce Dobkin; Gary Ford; Richard Greenwood; David Howard; Masud Husain; Malcolm Macleod; Randolph Nudo; John Rothwell; Anthony Rudd; James Teo; Nicholas Ward; Steven Wolf
Journal:  Neurorehabil Neural Repair       Date:  2009-02       Impact factor: 3.919

7.  Functional connectivity and cognitive changes after donepezil treatment in healthy participants.

Authors:  P Péran; A S Salabert; T Dondaine; X Leclerc; H Gros-Dagnac; J-P Ranjeva; R Lopes; L Lanteaume; O Blin; C Thalamas; R Bordet; P Payoux
Journal:  Psychopharmacology (Berl)       Date:  2021-08-09       Impact factor: 4.530

Review 8.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

9.  Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa.

Authors:  Kristin M Pearson-Fuhrhop; Brian Minton; Daniel Acevedo; Babak Shahbaba; Steven C Cramer
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 10.  Pharmacologic approaches to cerebral aging and neuroplasticity: insights from the stroke model.

Authors:  François Chollet
Journal:  Dialogues Clin Neurosci       Date:  2013-03       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.